CTOs on the Move

Centrix Inc.

www.centrixdental.com

 
Centrix, Inc. manufactures and sells a complete line of dental products to the dental industry. We do this through a hybrid marketing channel of both direct and dealer distributor sales.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Cantel Medical

Cantel Medical is a leading global company dedicated to delivering innovative infection prevention products and services for patients, caregivers, and other healthcare providers which improve outcomes, enhance safety and help save lives. Our products include specialized medical device reprocessing systems for endoscopy and renal dialysis, advanced water purification equipment, sterilants, disinfectants and cleaners, sterility assurance monitoring products for hospitals and dental clinics, disposable infection control products primarily for dental and GI endoscopy markets, dialysate concentrates, hollow fiber membrane filtration and separation products. Additionally, we provide technical service for our products.

Mayo Clinic Health System

Mayo Clinic Health System is a system of community-based medical facilities.

Addiction Recovery Resources (ARR)

Addiction Recovery Resources (ARR) is a Metairie, LA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CALSTAR, California Shock Trauma Air Rescue

CALSTAR, California Shock Trauma Air Rescue is a Mcclellan, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. is a leading innovative chemistry products and services provider throughout the pharmaceutical R&D process. Its core businesses include: a catalog of specially designed scaffolds and building blocks; custom synthesis; process development; manufacturing of key intermediates and RSMs; and FTE services. The company was listed on Shenzhen Exchange Stock in China on November 10, 2017. PharmaBlock has rapidly gained recognition for its outstanding capability in the design, synthesis, and supply of lab scale building blocks. Building on that success, the company acquired Shandong Diai Biotechnology Co., Ltd. as its pilot plant and manufacturing site in 2016, and is providing scale-up synthesis and manufacturing of key intermediates/RSMs. PharmaBlock is now committed to a more comprehensive and long-term service to valued customers.